Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuping Li

Showing results (411-420 of 436) with videos related to

Pageof 44
Sort By:
Biorxiv : the Preprint Server for Biology|September 10, 2024
AcrIF11 is a potent CRISPR-specific ADP-ribosyltransferase encoded by phage and plasmidDaphne F Chen, Leah T Roe, Yuping Li, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2015
Piwi-Interacting RNAs (piRNAs) Are Dysregulated in Renal Cell Carcinoma and Associated with Tumor Metastasis and Cancer-Specific SurvivalYuping Li, Xiwei Wu, Hanlin Gao, et al.
Cell Reports. Medicine|December 17, 2025
Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapyAlec J Hirsch, Amanda de Andrade Costa, Cody German, et al.
The Lancet Regional Health. Western Pacific|July 12, 2024
Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic <i>EGFR</i> mutation-positive non-small cell lung cancerYuankai Shi, Gongyan Chen, Xiang Wang, et al.
Critical Care Medicine|March 3, 2016
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral PneumoniaBin Cao, Hainv Gao, Boping Zhou, et al.
Leukemia|December 9, 2025
Key regulatory roles of PRDM1 in human NK-cell differentiation and activationXuxiang Liu, Yunfei Shi, Jibin Zhang, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseKevin Dang, Giulia Castello, Starlynn C Clarke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 28, 2021
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)Caicun Zhou, Lin Wu, Yun Fan, et al.
Neuro-Oncology|April 17, 2021
Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative propertiesMarie N M Volmar, Jiying Cheng, Haitham Alenezi, et al.
Blood|August 14, 2015
IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphomaChao Wang, Timothy W McKeithan, Qiang Gong, et al.
Pageof 44

Showing results (411-420 of 436) with videos related to

Sort By:
Pageof 44
Biorxiv : the Preprint Server for Biology|September 10, 2024
AcrIF11 is a potent CRISPR-specific ADP-ribosyltransferase encoded by phage and plasmidDaphne F Chen, Leah T Roe, Yuping Li, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2015
Piwi-Interacting RNAs (piRNAs) Are Dysregulated in Renal Cell Carcinoma and Associated with Tumor Metastasis and Cancer-Specific SurvivalYuping Li, Xiwei Wu, Hanlin Gao, et al.
Cell Reports. Medicine|December 17, 2025
Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapyAlec J Hirsch, Amanda de Andrade Costa, Cody German, et al.
The Lancet Regional Health. Western Pacific|July 12, 2024
Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic <i>EGFR</i> mutation-positive non-small cell lung cancerYuankai Shi, Gongyan Chen, Xiang Wang, et al.
Critical Care Medicine|March 3, 2016
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral PneumoniaBin Cao, Hainv Gao, Boping Zhou, et al.
Leukemia|December 9, 2025
Key regulatory roles of PRDM1 in human NK-cell differentiation and activationXuxiang Liu, Yunfei Shi, Jibin Zhang, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseKevin Dang, Giulia Castello, Starlynn C Clarke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 28, 2021
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)Caicun Zhou, Lin Wu, Yun Fan, et al.
Neuro-Oncology|April 17, 2021
Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative propertiesMarie N M Volmar, Jiying Cheng, Haitham Alenezi, et al.
Blood|August 14, 2015
IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphomaChao Wang, Timothy W McKeithan, Qiang Gong, et al.
Pageof 44